查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1887115

醫療營養市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察，以及2024-2032年預測

Medical Nutrition Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 195 Pages | 商品交期: 請詢問到貨日

價格

醫療營養市場成長因素

隨著慢性病發病率的上升、臨床營養意識的增強以及全球醫療保健系統日益認識到營養療法在急長期照護中的重要性，全球醫療營養市場持續穩步增長。根據本報告，在全球人口老化和醫療營養療法（MNT）需求不斷增長的推動下，2024年市場規模達到512.6億美元。預計2025年，市場規模將進一步成長至529.4億美元，2032年將達到850.5億美元，預測期內複合年增長率（CAGR）為7.0%。 2024年，北美地區引領全球市場，佔總營收的34.96%。這得益於該地區完善的醫療保健基礎設施、慢性病高發生率以及為推進臨床營養解決方案而不斷擴大的合作關係。

市場關鍵洞察

醫學營養療法 (MNT) 是一種個人化的營養幹預措施，用於管理糖尿病、胃腸道疾病、心血管疾病、慢性呼吸系統疾病和腎臟疾病等。這種方法利用臨床營養師提供的營養教育和行為諮詢，作為多學科醫療照護的一部分。近年來，由於全球對營養在預防和管理慢性病方面重要性的認識不斷提高，市場需求激增。

市場處於半一體化狀態，主要參與者包括雅培、雀巢、紐迪希亞（達能）、貝朗、費森尤斯卡比和利潔時集團。這些公司不斷擴展其產品組合併獲得監管部門的批准，以推出針對特定疾病和以患者為中心的營養產品。例如，2023年4月，紐迪希亞（Nutricia）在美國推出了一款支持突觸強化的記憶力補充劑。

市場動態

驅動因素：慢性疾病負擔加重

慢性疾病盛行率的不斷上升顯著推動了市場需求。癌症、帕金森氏症和神經系統疾病等疾病常常會影響正常的營養攝取。根據美國國家帕金森氏症協會統計，到2030年，北美將有130萬人罹患帕金森氏症。同樣，老化也是需要臨床營養治療的慢性疾病的主要驅動因素。在美國，預計2022年65歲以上人口將佔總人口的17.3%，到2040年將達到22.0%。

人們對家庭醫療營養日益增長的興趣也在推動市場需求。由於便利性、更高的行動能力和更好的生活質量，老年患者越來越傾向於在家中接受臨床營養服務。

阻礙因素：有限的報銷政策

特殊醫學用途食品和營養療法的保險覆蓋範圍因地區而異。雖然法國、德國、西班牙和荷蘭等歐洲國家提供充足的報銷，但在美國，醫院外的報銷範圍有限。這限制了低收入患者獲得服務的機會。此外，缺乏臨床營養技術研究的經濟誘因可能會阻礙創新。

機會：人工智慧驅動的個人化營養

對疾病特異性和個人化營養產品的需求不斷增長，為製造商帶來了巨大的機會。像雅培這樣的公司正在加大對人工智慧驅動的營養解決方案的研發投入（到2023年將達到27.41億美元），用於治療胃腸道疾病、免疫健康和代謝性疾病。人工智慧的進步使得為重症患者提供精準營養輸送和即時監測成為可能。

市場趨勢

一個關鍵的市場趨勢是轉向疾病特異性配方，包括針對癌症、腎臟病和代謝紊亂的配方。各公司正在推出專門的配方以改善治療效果。例如，雅培推出了 Similac PM 60/40 代謝配方，以幫助患有某些腎臟疾病的嬰兒。

個人化營養也正在蓬勃發展，尤其是在日本，53% 的消費者表示對個人化營養解決方案感興趣。此外，全球對預防醫學的關注度也不斷提高，這使得臨床營養成為疾病預防的重要工具。

區域展望

北美

北美引領全球市場，預計到 2024 年市場規模將達到 179.2 億美元，主要得益於強大的研發、產品發表和合作關係。各公司經常在美國主要的醫學會議上展示新的解決方案。百特公司於 2022 年推出的 ExactaMix Pro 就是該地區創新不斷增長的一個例子。

歐洲

在有利的醫保報銷政策和強有力的研究合作（例如費森尤斯卡比與歐洲重症監護醫學中心 (ESICM) 的合作）的推動下，歐洲將在 2024 年佔第二大市場佔有率。該合作支持臨床營養教育和重症監護營養。

亞太地區

預計亞太地區在 2025 年至 2032 年間將保持溫和增長，這主要得益於人口老化加劇以及人們對特定疾病營養的認識不斷提高。中國、印度和日本的經濟發展和醫療保健支出的成長正在推動市場擴張。

拉丁美洲與中東/非洲

由於醫療保健服務的改善、慢性病盛行率的上升以及人們對營養療法的認識不斷提高，這些地區將實現穩步增長。

2025年至2032年的複合年增長率將為7.0%。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • 各國及各次區域主要慢性病盛行率（2023/2024）
  • 主要公司新產品發布
  • 主要產業趨勢（併購、合作及其他）

第五章：全球醫療營養市場分析、洞察與預測（2019-2032）

  • 市場分析、洞察與預測 - 依類型劃分
    • 服務
      • 營養評估
      • 膳食準備與配送
      • 餵食輔助
      • 其他
    • 產品
      • 靜脈營養
      • 腸外營養
  • 市場分析、洞察與預測 - 依年齡組別劃分
    • 成人
    • 兒童
  • 市場分析、洞察與預測 - 依給藥途徑劃分
    • 口服
    • 鼻內給藥
    • 腸外給藥
    • 其他
  • 市場分析、洞察與預測 - 依劑量劃分劑型
    • 粉劑
    • 液體
  • 市場分析、洞察與預測 - 依治療領域劃分
    • 腫瘤科
    • 神經系統疾病
    • 胃腸病科
    • 糖尿病
    • 腎病
    • 心血管疾病
    • 其他
  • 市場分析、洞察與預測 - 依最終用戶劃分
    • 醫院及門診手術中心
    • 專科診所
    • 家庭醫療保健機構
    • 其他
  • 市場分析、洞察與預測 - 依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美醫療營養市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲醫療營養市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 歐洲其他地區

第八章：亞太地區醫療營養市場分析、洞察與預測（2019-2032）

  • 依國家/地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲醫療營養市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲醫療營養市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 海灣合作委員會
    • 南非
    • 中東和非洲其他地區

第十一章：競爭格局分析

  • 全球市佔率分析（2024）
  • 公司簡介
    • 雅培
    • 貝朗集團
    • 雀巢
    • 紐迪希亞（達能）
    • 百特
    • 費森尤斯卡比
    • 利潔時集團
    • Addus HomeCare, Inc.
    • 美德瑞集團
    • 味之素株式會社
Product Code: FBI112915

Growth Factors of medical nutrition Market

The global medical nutrition market continues to expand steadily as chronic diseases rise, awareness of clinical nutrition grows, and healthcare systems worldwide increasingly recognize the importance of nutrition therapy in both acute and long-term care. According to the report, the market size reached USD 51.26 billion in 2024, driven by an aging global population and increasing demand for medical nutrition therapy (MNT). The market is projected to grow further to USD 52.94 billion in 2025 and eventually reach USD 85.05 billion by 2032, reflecting a 7.0% CAGR during the forecast period. North America dominated the global market in 2024, accounting for 34.96% of total revenue due to its strong healthcare infrastructure, high prevalence of chronic diseases, and growing partnerships to advance clinical nutrition solutions.

Key Market Insights

Medical Nutrition Therapy (MNT) involves tailored nutrition interventions used to manage conditions such as diabetes, gastrointestinal disorders, cardiovascular diseases, chronic respiratory illness, and kidney disease. This treatment utilizes nutrition education and behavioral counseling delivered by clinical dietitians as part of multidisciplinary medical care. In recent years, demand has surged due to growing global awareness about the importance of nutrition in preventing and managing chronic conditions.

The market is semi-consolidated with major players such as Abbott, Nestle, Nutricia (Danone), B. Braun SE, Fresenius Kabi AG, and Reckitt Benckiser Group PLC. These companies continue to expand portfolios and secure regulatory approvals to introduce disease-specific and patient-focused nutritional products. For example, in April 2023, Nutricia launched a memory supplement in the U.S. to support synapse strengthening.

Market Dynamics

Drivers: Rising Burden of Chronic Diseases

The increasing prevalence of chronic illnesses significantly boosts market demand. Conditions such as cancer, Parkinson's disease, and neurological disorders often impair normal nutrient intake. According to the American Parkinson Disease Association, 1.3 million people in North America will be living with Parkinson's disease by 2030. Similarly, aging populations contribute heavily to chronic conditions requiring clinical nutrition. In the U.S., 17.3% of the population was aged 65+ in 2022, a number projected to reach 22.0% by 2040.

Growing awareness of home-based medical nutrition also fuels demand, as elderly patients increasingly prefer clinical nutrition services at home for convenience, improved mobility, and enhanced quality of life.

Restraints: Limited Reimbursement Policies

Coverage for medical foods and nutrition therapies varies widely across regions. While countries in Europe such as France, Germany, Spain, and the Netherlands offer substantial reimbursement, the U.S. provides limited coverage outside hospital settings. This restricts access for lower-income patients. Additionally, lack of financial incentives for research in clinical nutrition technologies can deter innovation.

Opportunities: AI-Powered Personalized Nutrition

Rising demand for disease-specific and personalized nutrition products creates significant opportunities for manufacturers. Companies such as Abbott are increasing R&D investments-USD 2,741.0 million in 2023-into AI-enhanced nutrition solutions for gastrointestinal disorders, immune health, and metabolic conditions. Advances in AI are enabling accurate nutrition delivery and real-time monitoring for critically ill patients.

Market Trends

A major trend in the market is the shift toward disease-specific formulations, such as those for oncology, renal disorders, and metabolic diseases. Companies are launching specialized formulas to improve treatment outcomes. For instance, Abbott introduced its Similac PM 60/40 metabolic formula to support infants with specific renal conditions.

Personalized nutrition is also gaining traction, particularly in Japan, where 53% of consumers express interest in tailored nutritional solutions. Additionally, global focus on preventive healthcare is rising, positioning clinical nutrition as an essential tool for disease prevention.

Regional Outlook

North America

North America led the global market with a value of USD 17.92 billion in 2024, supported by strong R&D, product launches, and collaborations. Companies frequently introduce new solutions at major U.S. medical conferences. Baxter's ExactaMix Pro launch in 2022 is an example of growing innovation in the region.

Europe

Europe held the second-largest share in 2024, driven by favorable reimbursement policies and strong research collaborations like the Fresenius Kabi-ESICM partnership supporting clinical nutrition education and critical care nutrition.

Asia Pacific

Asia Pacific is expected to grow moderately from 2025 to 2032, fueled by an expanding elderly population and rising awareness of disease-specific nutrition. Economic development and increased healthcare spending are supporting market expansion in China, India, and Japan.

Latin America and Middle East & Africa

These regions are witnessing steady growth due to improving healthcare access, rising chronic diseases, and increased awareness of nutrition therapy.

Conclusion

Driven by rising chronic diseases, aging populations, and increased focus on personalized care, the medical nutrition market will grow from USD 51.26 billion in 2024 to USD 85.05 billion by 2032. Continued innovation, AI-integrated nutrition solutions, and strategic collaborations will shape the future of clinical nutrition worldwide.

Growth rate CAGR of 7.0% from 2025-2032

Segmentation

By Type

  • Service
    • Nutrition Assessment
    • Meal Preparation & Delivery
    • Feeding Assistance
    • Others
  • Product
    • Enteral Nutrition
    • Parenteral Nutrition
  • Partial Parenteral Nutrition (PPN)
  • Total Parenteral Nutrition (TPN)

By Age Group

    • Adults
    • Pediatrics

By Route of Administration

  • Oral
  • Nasal
  • Parenteral
  • Others

By Form

  • Powder
  • Liquid

By Therapeutic Area

  • Oncology
  • Neurological Disorders
  • Gastrointestinal Disorders
  • Diabetes
  • Kidney Disorders
  • Cardiovascular Disorders
  • Others

By End-user

  • Hospitals & ASCs
  • Specialty Clinics
  • Homecare Settings
  • Others

By Region

  • North America (By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
    • U.S.
    • Canada
  • Europe ( By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of the Asia Pacific
  • Latin America (By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Age Group, By Route of Administration, By Form, By Therapeutic Area, By End-user, By Country/Sub-region)
    • GCC
    • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Chronic Diseases, by Key Countries/Sub-regions, 2023/2024
  • 4.2. New Product Launches, by Key Players
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Service
      • 5.1.1.1. Nutrition Assessment
      • 5.1.1.2. Meal Preparation & Delivery
      • 5.1.1.3. Feeding Assistance
      • 5.1.1.4. Others
    • 5.1.2. Product
      • 5.1.2.1. Enteral Nutrition
      • 5.1.2.2. Parenteral Nutrition
        • 5.1.2.2.1. Partial Parenteral Nutrition (PPN)
        • 5.1.2.2.2. Total Parenteral Nutrition (TPN)
  • 5.2. Market Analysis, Insights and Forecast - By Age Group
    • 5.2.1. Adults
    • 5.2.2. Pediatrics
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Oral
    • 5.3.2. Nasal
    • 5.3.3. Parenteral
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Form
    • 5.4.1. Powder
    • 5.4.2. Liquid
  • 5.5. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 5.5.1. Oncology
    • 5.5.2. Neurological Disorders
    • 5.5.3. Gastrointestinal Disorders
    • 5.5.4. Diabetes
    • 5.5.5. Kidney Disorders
    • 5.5.6. Cardiovascular Disorders
    • 5.5.7. Others
  • 5.6. Market Analysis, Insights and Forecast - By End-user
    • 5.6.1. Hospitals & ASCs
    • 5.6.2. Specialty Clinics
    • 5.6.3. Homecare Settings
    • 5.6.4. Others
  • 5.7. Market Analysis, Insights and Forecast - By Region
    • 5.7.1. North America
    • 5.7.2. Europe
    • 5.7.3. Asia Pacific
    • 5.7.4. Latin America
    • 5.7.5. Middle East & Africa

6. North America Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Service
      • 6.1.1.1. Nutrition Assessment
      • 6.1.1.2. Meal Preparation & Delivery
      • 6.1.1.3. Feeding Assistance
      • 6.1.1.4. Others
    • 6.1.2. Product
      • 6.1.2.1. Enteral Nutrition
      • 6.1.2.2. Parenteral Nutrition
        • 6.1.2.2.1. Partial Parenteral Nutrition (PPN)
        • 6.1.2.2.2. Total Parenteral Nutrition (TPN)
  • 6.2. Market Analysis, Insights and Forecast - By Age Group
    • 6.2.1. Adults
    • 6.2.2. Pediatrics
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Nasal
    • 6.3.3. Parenteral
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Form
    • 6.4.1. Powder
    • 6.4.2. Liquid
  • 6.5. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 6.5.1. Oncology
    • 6.5.2. Neurological Disorders
    • 6.5.3. Gastrointestinal Disorders
    • 6.5.4. Diabetes
    • 6.5.5. Kidney Disorders
    • 6.5.6. Cardiovascular Disorders
    • 6.5.7. Others
  • 6.6. Market Analysis, Insights and Forecast - By End-user
    • 6.6.1. Hospitals & ASCs
    • 6.6.2. Specialty Clinics
    • 6.6.3. Homecare Settings
    • 6.6.4. Others
  • 6.7. Market Analysis, Insights and Forecast - By Country
    • 6.7.1. U.S.
    • 6.7.2. Canada

7. Europe Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Service
      • 7.1.1.1. Nutrition Assessment
      • 7.1.1.2. Meal Preparation & Delivery
      • 7.1.1.3. Feeding Assistance
      • 7.1.1.4. Others
    • 7.1.2. Product
      • 7.1.2.1. Enteral Nutrition
      • 7.1.2.2. Parenteral Nutrition
        • 7.1.2.2.1. Partial Parenteral Nutrition (PPN)
        • 7.1.2.2.2. Total Parenteral Nutrition (TPN)
  • 7.2. Market Analysis, Insights and Forecast - By Age Group
    • 7.2.1. Adults
    • 7.2.2. Pediatrics
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Oral
    • 7.3.2. Nasal
    • 7.3.3. Parenteral
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Form
    • 7.4.1. Powder
    • 7.4.2. Liquid
  • 7.5. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 7.5.1. Oncology
    • 7.5.2. Neurological Disorders
    • 7.5.3. Gastrointestinal Disorders
    • 7.5.4. Diabetes
    • 7.5.5. Kidney Disorders
    • 7.5.6. Cardiovascular Disorders
    • 7.5.7. Others
  • 7.6. Market Analysis, Insights and Forecast - By End-user
    • 7.6.1. Hospitals & ASCs
    • 7.6.2. Specialty Clinics
    • 7.6.3. Homecare Settings
    • 7.6.4. Others
  • 7.7. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.7.1. Germany
    • 7.7.2. U.K.
    • 7.7.3. France
    • 7.7.4. Italy
    • 7.7.5. Spain
    • 7.7.6. Scandinavia
    • 7.7.7. Rest of Europe

8. Asia Pacific Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Service
      • 8.1.1.1. Nutrition Assessment
      • 8.1.1.2. Meal Preparation & Delivery
      • 8.1.1.3. Feeding Assistance
      • 8.1.1.4. Others
    • 8.1.2. Product
      • 8.1.2.1. Enteral Nutrition
      • 8.1.2.2. Parenteral Nutrition
        • 8.1.2.2.1. Partial Parenteral Nutrition (PPN)
        • 8.1.2.2.2. Total Parenteral Nutrition (TPN)
  • 8.2. Market Analysis, Insights and Forecast - By Age Group
    • 8.2.1. Adults
    • 8.2.2. Pediatrics
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Oral
    • 8.3.2. Nasal
    • 8.3.3. Parenteral
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Form
    • 8.4.1. Powder
    • 8.4.2. Liquid
  • 8.5. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 8.5.1. Oncology
    • 8.5.2. Neurological Disorders
    • 8.5.3. Gastrointestinal Disorders
    • 8.5.4. Diabetes
    • 8.5.5. Kidney Disorders
    • 8.5.6. Cardiovascular Disorders
    • 8.5.7. Others
  • 8.6. Market Analysis, Insights and Forecast - By End-user
    • 8.6.1. Hospitals & ASCs
    • 8.6.2. Specialty Clinics
    • 8.6.3. Homecare Settings
    • 8.6.4. Others
  • 8.7. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.7.1. China
    • 8.7.2. India
    • 8.7.3. Japan
    • 8.7.4. Australia
    • 8.7.5. Southeast Asia
    • 8.7.6. Rest of Asia Pacific

9. Latin America Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Service
      • 9.1.1.1. Nutrition Assessment
      • 9.1.1.2. Meal Preparation & Delivery
      • 9.1.1.3. Feeding Assistance
      • 9.1.1.4. Others
    • 9.1.2. Product
      • 9.1.2.1. Enteral Nutrition
      • 9.1.2.2. Parenteral Nutrition
        • 9.1.2.2.1. Partial Parenteral Nutrition (PPN)
        • 9.1.2.2.2. Total Parenteral Nutrition (TPN)
  • 9.2. Market Analysis, Insights and Forecast - By Age Group
    • 9.2.1. Adults
    • 9.2.2. Pediatrics
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Oral
    • 9.3.2. Nasal
    • 9.3.3. Parenteral
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Form
    • 9.4.1. Powder
    • 9.4.2. Liquid
  • 9.5. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 9.5.1. Oncology
    • 9.5.2. Neurological Disorders
    • 9.5.3. Gastrointestinal Disorders
    • 9.5.4. Diabetes
    • 9.5.5. Kidney Disorders
    • 9.5.6. Cardiovascular Disorders
    • 9.5.7. Others
  • 9.6. Market Analysis, Insights and Forecast - By End-user
    • 9.6.1. Hospitals & ASCs
    • 9.6.2. Specialty Clinics
    • 9.6.3. Homecare Settings
    • 9.6.4. Others
  • 9.7. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.7.1. Brazil
    • 9.7.2. Mexico
    • 9.7.3. Rest of Latin America

10. Middle East & Africa Medical Nutrition Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Service
      • 10.1.1.1. Nutrition Assessment
      • 10.1.1.2. Meal Preparation & Delivery
      • 10.1.1.3. Feeding Assistance
      • 10.1.1.4. Others
    • 10.1.2. Product
      • 10.1.2.1. Enteral Nutrition
      • 10.1.2.2. Parenteral Nutrition
        • 10.1.2.2.1. Partial Parenteral Nutrition (PPN)
        • 10.1.2.2.2. Total Parenteral Nutrition (TPN)
  • 10.2. Market Analysis, Insights and Forecast - By Age Group
    • 10.2.1. Adults
    • 10.2.2. Pediatrics
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Oral
    • 10.3.2. Nasal
    • 10.3.3. Parenteral
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Form
    • 10.4.1. Powder
    • 10.4.2. Liquid
  • 10.5. Market Analysis, Insights and Forecast - By Therapeutic Area
    • 10.5.1. Oncology
    • 10.5.2. Neurological Disorders
    • 10.5.3. Gastrointestinal Disorders
    • 10.5.4. Diabetes
    • 10.5.5. Kidney Disorders
    • 10.5.6. Cardiovascular Disorders
    • 10.5.7. Others
  • 10.6. Market Analysis, Insights and Forecast - By End-user
    • 10.6.1. Hospitals & ASCs
    • 10.6.2. Specialty Clinics
    • 10.6.3. Homecare Settings
    • 10.6.4. Others
  • 10.7. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.7.1. GCC
    • 10.7.2. South Africa
    • 10.7.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Abbott
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. Financials (Based on Availability)
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. SWOT,Etc.
    • 11.2.2. B. Braun SE
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. Financials (Based on Availability)
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. SWOT,Etc.
    • 11.2.3. Nestle
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. Financials (Based on Availability)
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. SWOT,Etc.
    • 11.2.4. Nutricia (Danone)
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. Financials (Based on Availability)
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. SWOT,Etc.
    • 11.2.5. Baxter
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. Financials (Based on Availability)
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. SWOT,Etc.
    • 11.2.6. Fresenius Kabi AG
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. Financials (Based on Availability)
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. SWOT,Etc.
    • 11.2.7. Reckitt Benckiser Group PLC
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. Financials (Based on Availability)
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. SWOT,Etc.
    • 11.2.8. Addus HomeCare, Inc.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. Financials (Based on Availability)
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. SWOT,Etc.
    • 11.2.9. Medtrition Inc.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. Financials (Based on Availability)
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. SWOT,Etc.
    • 11.2.10. Ajinomoto Co., Inc.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & services
      • 11.2.10.3. Financials (Based on Availability)
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. SWOT,Etc.

List of Tables

  • Table 1: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 2: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Service, 2019-2032
  • Table 3: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 4: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Parenteral Nutrition, 2019-2032
  • Table 5: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 6: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 7: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Form, 2019-2032
  • Table 8: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Therapeutic Area, 2019-2032
  • Table 9: Global Medical Nutrition Market Revenue (USD billion) Forecast, by End-user, 2019-2032
  • Table 10: Global Medical Nutrition Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 11: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 12: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Service, 2019-2032
  • Table 13: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 14: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Parenteral Nutrition, 2019-2032
  • Table 15: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 16: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 17: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Form, 2019-2032
  • Table 18: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Therapeutic Area, 2019-2032
  • Table 19: North America Medical Nutrition Market Revenue (USD billion) Forecast, by End-user, 2019-2032
  • Table 20: North America Medical Nutrition Market Revenue (USD billion) Forecast, by Country, 2019-2032
  • Table 21: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 22: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Service, 2019-2032
  • Table 23: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 24: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Parenteral Nutrition, 2019-2032
  • Table 25: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 26: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 27: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Form, 2019-2032
  • Table 28: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Therapeutic Area, 2019-2032
  • Table 29: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by End-user, 2019-2032
  • Table 30: Europe Medical Nutrition Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 31: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 32: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Service, 2019-2032
  • Table 33: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 34: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Parenteral Nutrition, 2019-2032
  • Table 35: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 36: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 37: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Form, 2019-2032
  • Table 38: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Therapeutic Area, 2019-2032
  • Table 39: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by End-user, 2019-2032
  • Table 40: Asia Pacific Medical Nutrition Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 41: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 42: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Service, 2019-2032
  • Table 43: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 44: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Parenteral Nutrition, 2019-2032
  • Table 45: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 46: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 47: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Form, 2019-2032
  • Table 48: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Therapeutic Area, 2019-2032
  • Table 49: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by End-user, 2019-2032
  • Table 50: Latin America Medical Nutrition Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032
  • Table 51: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 52: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Service, 2019-2032
  • Table 53: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 54: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Parenteral Nutrition, 2019-2032
  • Table 55: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Age Group, 2019-2032
  • Table 56: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 57: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Form, 2019-2032
  • Table 58: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Therapeutic Area, 2019-2032
  • Table 59: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by End-user, 2019-2032
  • Table 60: Middle East & Africa Medical Nutrition Market Revenue (USD billion) Forecast, by Country/Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Medical Nutrition Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Medical Nutrition Market Value Share (%), by Type, 2024 & 2032
  • Figure 3: Global Medical Nutrition Market Value Share (%), by Age Group, 2024 & 2032
  • Figure 4: Global Medical Nutrition Market Value Share (%), by Route of Administration, 2024 & 2032
  • Figure 5: Global Medical Nutrition Market Value Share (%), by Form, 2024 & 2032
  • Figure 6: Global Medical Nutrition Market Value Share (%), by Therapeutic Area, 2024 & 2032
  • Figure 7: Global Medical Nutrition Market Value Share (%), by End-user, 2024 & 2032
  • Figure 8: Global Medical Nutrition Market Value (USD billion), by Region, 2024 & 2032
  • Figure 9: North America Medical Nutrition Market Value (USD billion), by Type, 2024 & 2032
  • Figure 10: North America Medical Nutrition Market Value Share (%), by Type, 2024
  • Figure 11: North America Medical Nutrition Market Value (USD billion), by Age Group, 2024 & 2032
  • Figure 12: North America Medical Nutrition Market Value Share (%), by Age Group, 2024
  • Figure 13: North America Medical Nutrition Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 14: North America Medical Nutrition Market Value Share (%), by Route of Administration, 2024
  • Figure 15: North America Medical Nutrition Market Value (USD billion), by Form, 2024 & 2032
  • Figure 16: North America Medical Nutrition Market Value Share (%), by Form, 2024
  • Figure 17: North America Medical Nutrition Market Value (USD billion), by Therapeutic Area, 2024 & 2032
  • Figure 18: North America Medical Nutrition Market Value Share (%), by Therapeutic Area, 2024
  • Figure 19: North America Medical Nutrition Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 20: North America Medical Nutrition Market Value Share (%), by End-user, 2024
  • Figure 21: North America Medical Nutrition Market Value (USD billion), By Country, 2024 & 2032
  • Figure 22: North America Medical Nutrition Market Value Share (%), By Country, 2024
  • Figure 23: Europe Medical Nutrition Market Value (USD billion), by Type, 2024 & 2032
  • Figure 24: Europe Medical Nutrition Market Value Share (%), by Type, 2024
  • Figure 25: Europe Medical Nutrition Market Value (USD billion), by Age Group, 2024 & 2032
  • Figure 26: Europe Medical Nutrition Market Value Share (%), by Age Group, 2024
  • Figure 27: Europe Medical Nutrition Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 28: Europe Medical Nutrition Market Value Share (%), by Route of Administration, 2024
  • Figure 29: Europe Medical Nutrition Market Value (USD billion), by Form, 2024 & 2032
  • Figure 30: Europe Medical Nutrition Market Value Share (%), by Form, 2024
  • Figure 31: Europe Medical Nutrition Market Value (USD billion), by Therapeutic Area, 2024 & 2032
  • Figure 32: Europe Medical Nutrition Market Value Share (%), by Therapeutic Area, 2024
  • Figure 33: Europe Medical Nutrition Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 34: Europe Medical Nutrition Market Value Share (%), by End-user, 2024
  • Figure 35: Europe Medical Nutrition Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 36: Europe Medical Nutrition Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 37: Asia Pacific Medical Nutrition Market Value (USD billion), by Type, 2024 & 2032
  • Figure 38: Asia Pacific Medical Nutrition Market Value Share (%), by Type, 2024
  • Figure 39: Asia Pacific Medical Nutrition Market Value (USD billion), by Age Group, 2024 & 2032
  • Figure 40: Asia Pacific Medical Nutrition Market Value Share (%), by Age Group, 2024
  • Figure 41: Asia Pacific Medical Nutrition Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 42: Asia Pacific Medical Nutrition Market Value Share (%), by Route of Administration, 2024
  • Figure 43: Asia Pacific Medical Nutrition Market Value (USD billion), by Form, 2024 & 2032
  • Figure 44: Asia Pacific Medical Nutrition Market Value Share (%), by Form, 2024
  • Figure 45: Asia Pacific Medical Nutrition Market Value (USD billion), by Therapeutic Area, 2024 & 2032
  • Figure 46: Asia Pacific Medical Nutrition Market Value Share (%), by Therapeutic Area, 2024
  • Figure 47: Asia Pacific Medical Nutrition Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 48: Asia Pacific Medical Nutrition Market Value Share (%), by End-user, 2024
  • Figure 49: Asia Pacific Medical Nutrition Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 50: Asia Pacific Medical Nutrition Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 51: Latin America Medical Nutrition Market Value (USD billion), by Type, 2024 & 2032
  • Figure 52: Latin America Medical Nutrition Market Value Share (%), by Type, 2024
  • Figure 53: Latin America Medical Nutrition Market Value (USD billion), by Age Group, 2024 & 2032
  • Figure 54: Latin America Medical Nutrition Market Value Share (%), by Age Group, 2024
  • Figure 55: Latin America Medical Nutrition Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 56: Latin America Medical Nutrition Market Value Share (%), by Route of Administration, 2024
  • Figure 57: Latin America Medical Nutrition Market Value (USD billion), by Form, 2024 & 2032
  • Figure 58: Latin America Medical Nutrition Market Value Share (%), by Form, 2024
  • Figure 59: Latin America Medical Nutrition Market Value (USD billion), by Therapeutic Area, 2024 & 2032
  • Figure 60: Latin America Medical Nutrition Market Value Share (%), by Therapeutic Area, 2024
  • Figure 61: Latin America Medical Nutrition Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 62: Latin America Medical Nutrition Market Value Share (%), by End-user, 2024
  • Figure 63: Latin America Medical Nutrition Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 64: Latin America Medical Nutrition Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 65: Middle East & Africa Medical Nutrition Market Value (USD billion), by Type, 2024 & 2032
  • Figure 66: Middle East & Africa Medical Nutrition Market Value Share (%), by Type, 2024
  • Figure 67: Middle East & Africa Medical Nutrition Market Value (USD billion), by Age Group, 2024 & 2032
  • Figure 68: Middle East & Africa Medical Nutrition Market Value Share (%), by Age Group, 2024
  • Figure 69: Middle East & Africa Medical Nutrition Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 70: Middle East & Africa Medical Nutrition Market Value Share (%), by Route of Administration, 2024
  • Figure 71: Middle East & Africa Medical Nutrition Market Value (USD billion), by Form, 2024 & 2032
  • Figure 72: Middle East & Africa Medical Nutrition Market Value Share (%), by Form, 2024
  • Figure 73: Middle East & Africa Medical Nutrition Market Value (USD billion), by Therapeutic Area, 2024 & 2032
  • Figure 74: Middle East & Africa Medical Nutrition Market Value Share (%), by Therapeutic Area, 2024
  • Figure 75: Middle East & Africa Medical Nutrition Market Value (USD billion), by End-user, 2024 & 2032
  • Figure 76: Middle East & Africa Medical Nutrition Market Value Share (%), by End-user, 2024
  • Figure 77: Middle East & Africa Medical Nutrition Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 78: Middle East & Africa Medical Nutrition Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 79: Global Medical Nutrition Market Share (%), By Company, 2024